Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data at ASAIO 2026
Picard Medical and its subsidiary SynCardia will present new preclinical data and patient outcome research related to the Emperor Total Artificial Heart at the ASAIO 2026 Annual Conference. The conference will take place in New Orleans, Louisiana, from June 18-21, 2026. The presentations will focus on the hemodynamic performance of the next-generation artificial heart and real-world outcomes from patients using the SynCardia Total Artificial Heart.
Two scientific presentations highlight next-generation innovation and patient outcomes with total artificial heart support
Two scientific presentations highlight next-generation innovation and patient outcomes with total artificial heart support